- Home
- HTH vs IRON Comparison
HTH vs IRON Comparison
Compare HTH & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTH
- IRON
- Stock Information
- Founded
- HTH 1998
- IRON 2017
- Country
- HTH United States
- IRON United States
- Employees
- HTH N/A
- IRON N/A
- Industry
- HTH Major Banks
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- HTH Finance
- IRON Health Care
- Exchange
- HTH Nasdaq
- IRON Nasdaq
- Market Cap
- HTH 1.9B
- IRON 2.1B
- IPO Year
- HTH 2004
- IRON N/A
- Fundamental
- Price
- HTH $29.56
- IRON $58.97
- Analyst Decision
- HTH Hold
- IRON Strong Buy
- Analyst Count
- HTH 2
- IRON 12
- Target Price
- HTH $33.00
- IRON $92.08
- AVG Volume (30 Days)
- HTH 463.9K
- IRON 338.9K
- Earning Date
- HTH 07-24-2025
- IRON 08-11-2025
- Dividend Yield
- HTH 2.43%
- IRON N/A
- EPS Growth
- HTH 27.10
- IRON N/A
- EPS
- HTH 2.22
- IRON N/A
- Revenue
- HTH $1,233,449,000.00
- IRON N/A
- Revenue This Year
- HTH N/A
- IRON N/A
- Revenue Next Year
- HTH $1.36
- IRON N/A
- P/E Ratio
- HTH $13.34
- IRON N/A
- Revenue Growth
- HTH 4.92
- IRON N/A
- 52 Week Low
- HTH $26.67
- IRON $30.82
- 52 Week High
- HTH $34.68
- IRON $68.73
- Technical
- Relative Strength Index (RSI)
- HTH 37.83
- IRON 57.85
- Support Level
- HTH $29.98
- IRON $58.63
- Resistance Level
- HTH $31.72
- IRON $61.59
- Average True Range (ATR)
- HTH 0.62
- IRON 2.14
- MACD
- HTH -0.21
- IRON -0.24
- Stochastic Oscillator
- HTH 14.29
- IRON 51.40
About HTH Hilltop Holdings Inc.
Hilltop Holdings Inc is a Dallas-based financial holding company. The Company has two primary business units, PCC (banking and mortgage origination) and Securities Holdings (broker-dealer). The banking segment includes the operations of the Bank. The banking segment provides business and consumer banking services from offices located throughout Texas and generates revenue from its portfolio of earning assets. The broker-dealer segment includes the operations of Securities Holdings, which operates through its wholly owned subsidiaries Hilltop Securities, Asset Managment LLC, etc. The broker-dealer segment generates a majority of its revenues from fees and commissions earned from investment advisory and securities brokerage services. Majority of revenue is from Banking Segment.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.